Cornus officinalis vinegar reduces body weight and attenuates hepatic steatosis in mouse model of nonalcoholic fatty liver disease. Issue 7 (8th June 2022)

• Record Type: Journal Article
• Authors: Cao, Li; Wu, Ying; Li, Wenwen; Zhang, Zengmiao; Niu, Yaping; Li, Chenchen; Gu, Shaobin
• Is Part Of: Journal of food science. Volume 87:Issue 7(2022)
• Page Start: 3248
• Page End: 3259
• Publication Date: 2022-06-08
• Subjects: anti‐oxidant activity -- Cornus officinalis vinegar -- hepatic steatosis -- liver function -- nonalcoholic fatty liver disease; Food -- Periodicals; Food -- Research -- Periodicals; Food -- Periodicals; Research -- Periodicals; Levensmiddelen; Voeding; 664
• DOI: 10.1111/1750-3841.16178
• Languages: English
• ISSNs: 0022-1147

Abstract

Abstract: This study aimed to determine the main bioactive components of Cornus officinalis vinegar (COV) and assess the effects of COV on the body weight (BW) and hepatic steatosis in a nonalcoholic fatty liver disease (NAFLD) mouse model. Seven‐week‐old KM female mice were divided into five treatment groups: (1) Normal control (NC) group, (2) high fat diet (HFD) group, (3) low concentration treatment group (3.5% COV), (4) medium concentration treatment group (5.0% COV), and (5) high concentration treatment group (6.5% COV). Mice in the NC group were fed with a normal chow diet, and those in the other four groups were fed with a HFD known for causing obesity for 10 weeks. Then, mice in the three COV treatment groups were orally administered with COV once a day for 6 weeks. Results showed that the contents of loganin and morroniside in COV reached 16.82 and 51.17 µg/ml, respectively, and COV also contained multiple organic acids. COV significantly reduced BW, abdominal fat weight, liver weight, and the levels of glucose, triglyceride, and low‐density lipoprotein cholesterol of serum and increased the levels of high‐density lipoprotein cholesterol of serum ( p < 0.05). COV also improved the liver function and anti‐oxidant activity of liver ( p < 0.05). COV treatments increased the interleukin‐10 expression and reduced the tumor necrosis factor‐α expression in the liver tissue of NAFLD mice ( p < 0.05). Histopathological observation revealed that COV suppressed hepatic lipid accumulation and steatosis. The results suggest that COV may contribute to the alleviation of NAFLD and obesity.